Results 31 to 40 of about 164,611 (306)

Functional activity of PTEN isoforms and PTEN C-terminal truncations.

open access: yes, 2023
(A) COS‐7 cells were transfected with pRK5 empty vector (EV) or pRK5 encoding the distinct PTEN isoforms [PTEN, PTEN-Δ, PTEN-L/-M/-O(Met)], in combination with the pSG5 HA‐AKT1 plasmid, and cells were processed for immunoblot using anti-PTEN BA226, anti ...
Leire Torices (16726432)   +3 more
core   +1 more source

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. [PDF]

open access: yes, 2010
BACKGROUND: The discovery of ERG/ETV1 gene rearrangements and PTEN gene loss warrants investigation in a mechanism-based prognostic classification of prostate cancer (PCa).
P T Scardino   +65 more
core   +1 more source

DataSheet_1_TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro.zip

open access: yes, 2023
Glioblastoma (GBM) is fatal and the study of therapeutic resistance, disease progression, and drug discovery in GBM or glioma stem cells is often hindered by limited resources.
N. U. Farrukh Hameed (10001728)   +15 more
core   +1 more source

Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation

open access: yesCase Reports in Oncology, 2020
Prostate cancer is among the most common types of cancer in men. Early detection and proper medical intervention is crucial to ensuring successful treatment.
Jamie A. Kmak   +8 more
doaj   +1 more source

PTEN regulation by Akt–EGR1–ARF–PTEN axis [PDF]

open access: yesThe EMBO Journal, 2008
The PTEN tumour suppressor gene is induced by the early growth response 1 (EGR1) transcription factor, which also transactivates p53, p73, and p300/CBP as well as other proapoptotic and anti-cancer genes. Here, we describe a novel Akt-EGR1-alternate reading frame (ARF)-PTEN axis, in which PTEN activation in vivo requires p14ARF-mediated sumoylation of ...
Jianxiu, Yu   +11 more
openaire   +2 more sources

Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function [PDF]

open access: yes, 2019
The tumour suppressor PTEN is frequently downregulated, mutated or lost in several types of tumours and congenital disorders including PHTS (PTEN Hamartoma Tumour Syndrome) and ASD (Autism Spectrum Disorder).
Sandra Luna   +22 more
core   +1 more source

Knockdown of PTEN promotes colon cancer progression and induces M2 macrophage polarization in the colon cancer cell environment

open access: yesIndian Journal of Pathology and Microbiology, 2023
Objective: This article aims to study the effect of phosphate and tension homolog deleted on chromosome ten (PTEN) knockdown on colon cancer progression and macrophage polarization in the cancer environment.
Xu Han   +4 more
doaj   +1 more source

The nuclear affairs of PTEN [PDF]

open access: yesJournal of Cell Science, 2008
PTEN encodes a major tumor-suppressor protein that is a dual-specificity phosphatase. Inactivation of PTEN has been shown to be involved in heritable and sporadic cancers. Mutation or deletion of PTEN, historically the most commonly identified mechanisms of inactivation of tumor suppressors, is found only in the minority of sporadic non-cultured ...
Sarah M, Planchon   +2 more
openaire   +2 more sources

Fos co-operation with PTEN loss elicits keratoacanthoma not carcinoma due to p53/p21WAF-induced differentiation triggered by GSK3b inactivation and reduced AKT activity [PDF]

open access: yes, 2008
To investigate gene synergism in multistage skin carcinogenesis, the RU486-inducible cre/lox system was employed to ablate PTEN function [K14.cre/D5PTENflx] in mouse epidermis expressing activated v-fos [HK1.fos].
Chan, W-C.   +11 more
core   +1 more source

Table_1_TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro.docx

open access: yes, 2023
Glioblastoma (GBM) is fatal and the study of therapeutic resistance, disease progression, and drug discovery in GBM or glioma stem cells is often hindered by limited resources.
N. U. Farrukh Hameed (10001728)   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy